AstraZeneca UK Limited
193 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 6 name spellings.
2
Ending by 2030
Nov 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 16, 2026The maintenance fee for Methods for treatment of hypertension with an angiotensin II receptor blocker pharmaceutical composition (US 11,651,865) comes due Nov 16, 2026. Unpaid by May 17, 2027, it lapses early.
- 1 fee due Dec 18, 2026The maintenance fee for Systems and Methods for Facilitating Patient Self-Selection (US 10,325,678) comes due Dec 18, 2026. Unpaid by Jun 21, 2027, it lapses early.
- 1 fee due Mar 12, 2027The maintenance fee for Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition (US 11,756,656) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 4 fees due Apr 13 to 24, 2027 · next Apr 13
- 2 fees due May 14, 2027
- 1 fee due Jun 19, 2027The maintenance fee for Automated Detection of Safety Signals for Pharmacovigilance (US 11,847,415) comes due Jun 19, 2027. Unpaid by Dec 20, 2027, it lapses early.
- 1 fee due Jul 2, 2027The maintenance fee for N-(2-(4-Cyanothiazolidin-3-YL)-2-Oxoethyl)-QUINOLINE-4-Carboxamides (US 11,858,924) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Sep 24, 2027The maintenance fee for Systems and Methods for Dispensing a Statin Medication Over the Counter (US 10,600,502) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.
- 1 fee due Oct 30, 2027The maintenance fee for Systems and Methods for Dispensing a Statin Medication Over the Counter (US 11,972,844) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 17, 2026
- 4 terms have ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D671,207 | Inhaler In force · From the USPTO record | In force | From the USPTO record | |
| US 8,063,213 | Production of rosuvastatin calcium salt In force · From the USPTO record | In force | From the USPTO record | |
| US 8,252,802 | Chemical Compounds In force · High confidence | In force | High confidence | |
| US 10,028,953 | Pharmaceutical composition of rosuvastatin calcium In force · From the USPTO record | In force | From the USPTO record | |
| US 8,632,807 | Pharmaceutical composition In force · From the USPTO record | In force | From the USPTO record | |
| US 9,376,398 | Carboxylic acid compounds In force · From the USPTO record | In force | From the USPTO record | |
| US 9,156,831 | Chemical Compounds In force · High confidence | In force | High confidence | |
| US 11,787,786 | Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1 In force · From the USPTO record | In force | From the USPTO record | |
| US 10,325,678 | Systems and Methods for Facilitating Patient Self-Selection In force · High confidence | In force | High confidence | |
| US 10,910,091 | Systems and Methods for Dispensing a Statin Medication Over the Counter In force · High confidence | In force | High confidence |
Also on record, not counted in the 35: 193 patents in force now held by others · 224 lapsed for an unpaid fee · 319 ended at full term · 1 past the fee grace period · 2 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
17 pending · 38 abandoned · 29 no status recorded